Search results for #GU24
Updated Data on CHECKMATE 9ER!!! - EXTENDED FOLLOW UP... Oncology KOLs continue to address the Favourable Risk category data set. @myESMO #GU24 #ASCO 👉beta.kolpulse.com/public/1409290…
Today on #MashupMD, our editors revisit the #RCC roundtables from #GU24 and bring you the latest research in #GUOncology with the help of our friends at @GUOncologyNow. Check out essential reading on IO/IO vs. IO/TK treatment, #KEYNOTE564, and more: --- mashupmd.com/expert-collect…
Bridging clinical gaps in #ProstateCancer care. @Silke_Gillessen joins @CaPsurvivorship to discuss #APCCC24 and delves into how the conference will tackle crucial topics from @ASCO #GU24, highlighting the dynamic field of #PCa treatment > bit.ly/3uSMpmA @APCCC_Lugano
Bridging clinical gaps in #ProstateCancer care. @Silke_Gillessen joins @CaPsurvivorship to discuss #APCCC24 and delves into how the conference will tackle crucial topics from @ASCO #GU24, highlighting the dynamic field of #PCa treatment > bit.ly/3uSMpmA @APCCC_Lugano
Learn strategies from Matthew D. Galsky, MD (@MattGalsky), Shilpa Gupta, MD (@shilpaonc), & Andrea Necchi, MD (@AndreaNecchi) for incorporating novel therapies into clinical practice for patients with #BladderCancer. bit.ly/3MoOqN0 #GU24 #MedEd
🎥 Professor Stefan N. Symeonides shares his insights on the #KEYNOTE564 trial and the new data presented on overall survival at ASCO #GU24. -> medicaldigest.org/scientific-con… @EdiCancerCentre @ASCO #KidneyCancer #oncology #MedTwitter
Learn from Drs. @montypal, @PBarataMD, McDermott, & @TiansterZhang how to use team-based strategies for mitigating & managing adverse events to allow your patients with #RCC to continue to receive optimal care! With @kcCURE! bit.ly/3R4EsD4 #GU24
Bridging clinical gaps in #ProstateCancer care. @Silke_Gillessen joins @CaPsurvivorship to discuss #APCCC24 and delves into how the conference will tackle crucial topics from @ASCO #GU24, highlighting the dynamic field of #PCa treatment > bit.ly/3uSMpmA @APCCC_Lugano
Newly posted! Check out our Practice Aids on #RenalCellCarcinoma (#RCC) from our recently released activity from #GU24 with Drs. Kumar Pal (@montypal), Pedro C. Barata (@PBarataMD), David F. McDermott, and Tian Zhang (@TiansterZhang). With @kcCURE! bit.ly/3R4EsD4 #MedEd
Didn't make it to #GU24? Check out what you missed! Now available, useful #BladderCancer Practice Aids from our activity with @MattGalsky, @shilpaonc, & @AndreaNecchi. Produced with @BladderCancerUS: bit.ly/3MoOqN0 #Oncology #Urology #MedEd #MedTwitter
Sharpen your skills in designing personalized care plans that incorporate emerging #ProstateCancer therapeutics: Watch this video with Drs. Dreicer, Morgans, Shore, & Smith. Developed with @ZEROCancer: bit.ly/3sAgEOf #Oncology #MedEd #MedTwitter #GU24
Cabozantinib Plus Atezolizumab Improves Progression-Free Survival ascopost.com/issues/march-2… #pcsm #prostatecancer #oncology #GU24
With @RossLiao, @huitingruan, @DrOmarMian @PBarataMD and team, we churned out an @ASCO Ed Bk review for #GU24 on small cell cancers in ~2 months, without ever meeting in person - until afterwards to celebrate! @CleClinicUro @CleClinicUroRes @cwruhemeonc ascopubs.org/doi/pdf/10.120…
Bridging clinical gaps in #ProstateCancer care. @Silke_Gillessen joins @CaPsurvivorship to discuss #APCCC24 and delves into how the conference will tackle crucial topics from @ASCO #GU24, highlighting the dynamic field of #PCa treatment > bit.ly/3uSMpmA @APCCC_Lugano
🌟 Be part of a pivotal moment in advanced #prostatecancer managment at #APCCC24! Join global experts in consensus discussions that shape future treatments. 🗓️ Register now for an unmissable experience: apccc.org #Oncology #GU24 #oncoalert
Hear expert perspectives on how new safety and efficacy evidence for #BladderCancer treatments impact pts throughout the disease continuum. Featuring @MattGalsky, @shilpaonc, & @AndreaNecchi & @BladderCancerUS: bit.ly/3MoOqN0 #GU24 #MedEd #MedTwitter
Don't miss out on our recently released ProstateCancer treatment regimens Practice Aids from #GU24 featuring Drs. Dreicer, Morgans, Shore, & Smith. Produced with @ZEROCancer! Download here: bit.ly/3sAgEOf #MedEd #MedTwitter
Listen to expert perspectives on how new safety and efficacy evidence for #BladderCancer treatments impact patients throughout the disease continuum. Featuring @MattGalsky, @shilpaonc, & @AndreaNecch! Developed with our partner, @PeerView: bit.ly/3Tv7r4a #GU24 #MedEd
Enfortumab Vedotin Plus Pembrolizumab Yields Benefit in Key Subgroups With Advanced Urothelial Cancer ascopost.com/news/march-202… #blcsm #bladdercancer #oncology #immunotherapy #GU24
Tali Gueta @TaGu24
661 Followers 362 Following Product at @sightful, blogger, lecturer, geek, techie. I tweet about tech and product management.
24 @Gmu_gu
2 Followers 18 Following
24\7L @ViancaLuceroGu1
4 Followers 25 Following
Swish Cycles @SwishCycles
2K Followers 2K Following Service & choice, choice & service! Make it easy to get what you want, how you want it. Personal & professional service. Nationwide + GU24 8HU Fairoaks Airport
Gu24 @Gu24_
321 Followers 444 Following ¿Qué está pasando en la provincia de #Guadalajara? Te lo contamos de forma desinteresada y plural.
24.01.63 @dYuPahvPl5HjhGU
0 Followers 11 Following
24 @cJU1WkgbGu28204
0 Followers 1 Following
Rent GU24 Propertwee @Rent_GU24
1 Followers 0 Following
Rent GU24 Propertwee @rent_testingg
1 Followers 0 Following
gu24 @gufiw2499
1 Followers 10 Following
Dave Gu'24 @gu_dave
0 Followers 1 Following